ORBIS INVESTMENT MANAGEMENT LTD - 30 Sep 2025 SCHEDULE 13G Report for CRISPR Therapeutics AG Common Stock (CRSP)

Filing Manager: ORBIS INVESTMENT MANAGEMENT LTD
Reporting Manager: ORBIS INVESTMENT MANAGEMENT LTD
Security: CRISPR Therapeutics AG Common Stock
Symbol: CRSP
Shares outstanding: 90,438,636 shares
Disclosed Ownership: 4,974,125 shares
Ownership: 5.5%
Form type: SCHEDULE 13G
Filing time: 14 Nov 2025, 12:26:20 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIS INVESTMENT MANAGEMENT LTD	5.5%	4,974,125	4,974,125	0	Matthew Gaarder	Attorney-in-Fact
Allan Gray Australia Pty Ltd	0%	7,960	7,960	0	Matthew Gaarder	Attorney-in-Fact